Cystic partially differentiated nephroblastoma

Summary

Cystic partially differentiated nephroblastoma (MONDO:0030604) is a disease. A subtype of childhood multilocular cystic kidney neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	cystic partially differentiated nephroblastoma
Mondo ID	MONDO:0030604
DOID	DOID:7571
NCIT	C6897
UMLS	C1266139
MedGen	220423
GARD	0025603
Is cancer (heuristic)	no

Also known as: cystic partially differentiated nephroblastoma · malignant cystic nephroma · malignant multilocular cystic nephroma

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › childhood neoplasm › childhood kidney neoplasm › childhood multilocular cystic kidney neoplasm › cystic partially differentiated nephroblastoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.